Oxitropium bromide

This classification denotes a bronchodilator and antimuscarinic agent with the molecular formula C19H26NO4.Br, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier SF4NW7NH7C, chemically known as 3-oxa-9-azoniatricyclo(3.3.1.0(sup 2,4))nonane, 9-ethyl-7-(3-hydroxy-1-oxo-2-phenylpropoxy)-9-methyl-, bromide, (7(s)-(1-alpha,2-beta,4-beta,5-alpha,7-beta))- but more generally known as oxitropium bromide, which bears US NIH Compound Identifier 34875. European Medicines Agency schedules Oxitropium bromide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09543MIG. The term OXITROPIUM BROMIDE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 31, No10, 1977, List 17). World Health Organization schedules oxitropium bromide in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations, for tariff and trade purposes, schedule oxitropium bromide under HS 29399900 and SITC 54149. As of Q4 2014, OXITROPIUM BROMIDE remains US FDA's Preferred Term for this commodity. Oxitropium bromide bears US NLM identifiers UMLS ID C0134499 and NCI Concept Code C74157. SMILES: CC[N+]1([C@@H]2C[C@H](C[C@H]1[C@H]3[C@@H]2O3)OC(=O)[C@H](CO)C4CCCCC4)C.[BR-].